FERRARI, Stefania
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 14.277
EU - Europa 7.608
AS - Asia 5.747
SA - Sud America 879
Continente sconosciuto - Info sul continente non disponibili 299
AF - Africa 154
OC - Oceania 11
Totale 28.975
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 14.001
IT - Italia 2.105
GB - Regno Unito 2.034
SG - Singapore 1.732
CN - Cina 1.567
DE - Germania 891
VN - Vietnam 770
BR - Brasile 691
SE - Svezia 627
HK - Hong Kong 509
FR - Francia 439
RU - Federazione Russa 293
FI - Finlandia 263
UA - Ucraina 261
BD - Bangladesh 232
PL - Polonia 198
TR - Turchia 187
KR - Corea 161
IN - India 160
CA - Canada 146
BG - Bulgaria 93
NL - Olanda 80
JP - Giappone 66
MX - Messico 64
AR - Argentina 63
ID - Indonesia 62
IQ - Iraq 60
ZA - Sudafrica 52
BE - Belgio 45
IE - Irlanda 41
ES - Italia 40
AE - Emirati Arabi Uniti 35
CH - Svizzera 34
LT - Lituania 33
PK - Pakistan 31
AT - Austria 29
CL - Cile 23
EC - Ecuador 23
SA - Arabia Saudita 23
CO - Colombia 21
UZ - Uzbekistan 21
MA - Marocco 19
VE - Venezuela 19
MY - Malesia 18
PH - Filippine 18
CZ - Repubblica Ceca 15
PT - Portogallo 15
PY - Paraguay 15
DZ - Algeria 14
EG - Egitto 14
JM - Giamaica 14
AZ - Azerbaigian 12
JO - Giordania 12
DK - Danimarca 11
ET - Etiopia 11
IR - Iran 11
KE - Kenya 11
CR - Costa Rica 10
HU - Ungheria 10
PE - Perù 10
TN - Tunisia 10
BO - Bolivia 8
BY - Bielorussia 8
AU - Australia 7
BH - Bahrain 7
EU - Europa 7
AL - Albania 6
DO - Repubblica Dominicana 6
GT - Guatemala 6
RO - Romania 6
SN - Senegal 6
TW - Taiwan 6
UY - Uruguay 6
GR - Grecia 5
HN - Honduras 5
KZ - Kazakistan 5
MD - Moldavia 5
SV - El Salvador 5
AM - Armenia 4
BA - Bosnia-Erzegovina 4
LV - Lettonia 4
NI - Nicaragua 4
NP - Nepal 4
NZ - Nuova Zelanda 4
PA - Panama 4
TZ - Tanzania 4
GD - Grenada 3
HR - Croazia 3
IL - Israele 3
KG - Kirghizistan 3
LK - Sri Lanka 3
NG - Nigeria 3
PS - Palestinian Territory 3
RS - Serbia 3
SC - Seychelles 3
TH - Thailandia 3
TT - Trinidad e Tobago 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BB - Barbados 2
CI - Costa d'Avorio 2
Totale 28.650
Salva come PNG Salva come JPEG
Città #
Ashburn 1.472
Southend 1.466
Fairfield 1.294
Santa Clara 1.143
Singapore 1.057
Woodbridge 890
Chandler 753
Houston 602
San Jose 556
Seattle 530
Ann Arbor 512
Hong Kong 497
Cambridge 469
Jacksonville 468
Dearborn 458
Wilmington 444
Hefei 392
Frankfurt am Main 389
Nyköping 363
Council Bluffs 330
Beijing 290
Modena 277
London 242
Ho Chi Minh City 224
New York 200
Los Angeles 192
Hanoi 185
Helsinki 161
Seoul 146
Kraków 145
Milan 143
The Dalles 123
Chicago 122
Princeton 98
San Diego 92
Sofia 92
Izmir 91
Munich 89
Eugene 87
Shanghai 87
Moscow 85
Lauterbourg 82
Fremont 76
Orem 74
Redwood City 69
São Paulo 68
Buffalo 65
Rome 63
Boardman 60
Bologna 55
Porto Alegre 54
Columbus 50
Tokyo 49
Bremen 46
Da Nang 42
Dallas 42
Warsaw 42
Salt Lake City 41
Brussels 40
Dublin 40
Brooklyn 39
Naples 36
Des Moines 35
Atlanta 33
Guangzhou 32
Chennai 31
Jakarta 31
Verona 31
Denver 30
Grafing 30
Montreal 30
Toronto 29
Falls Church 28
Phoenix 28
Ottawa 27
Stockholm 27
Haiphong 26
Turku 26
Baghdad 25
Parma 24
Belo Horizonte 23
Cape Town 23
Amsterdam 22
Norwalk 22
Elk Grove Village 21
San Francisco 21
Marseille 19
Mumbai 19
Poplar 19
Tampa 19
Paris 18
Dhaka 17
Florence 17
Manchester 17
Mexico City 17
Reggio Emilia 17
Biên Hòa 16
Dong Ket 16
Milwaukee 16
Tashkent 16
Totale 19.287
Salva come PNG Salva come JPEG
Nome #
STRUTTURA DEL CRISTALLO DEL COMPLESSO DI TIMIDILATO SINTETASI (TS) CON UN LIGANDO 844
Protein–protein interface-binding peptides inhibit the cancer therapy target human thymidylate synthase 496
Optimization of Peptides That Target Human Thymidylate Synthase to Inhibit Ovarian Cancer Cell Growth 467
Metodo per la funzionalizzazione sito specifica di molecole proteiche 466
USO DI INIBITORI DELLA PTERIDINA REDUTTASI PER LA PREVENZIONE E/O IL TRATTAMENTO DI INFEZIONI PARASSITARIE 446
2-[N-Alkyl(R-phenyl)-aminomethyl]-3-phenyl-7-trifluoromethylquinoxalines as anticancer agents inhibitors of folate enzymes 444
2-Carboxyquinoxalines Kill Mycobacterium tuberculosis through Noncovalent Inhibition of DprE1 443
Virtual Screening and X-ray Crystallography Identify Non-Substrate Analog Inhibitors of Flavin-Dependent Thymidylate Synthase 435
Constrained dansyl derivatives reveal bacterial specificity of highly conserved Thymidylate Synthases A 433
Virtual screening identification of nonfolate compounds, including a CNS drug, as antiparasitic agents inhibiting pteridine reductase 432
Aryl thiosemicarbazones for the treatment of trypanosomatidic infections 424
Enhancement of Benzothiazoles as Pteridine Reductase-1 Inhibitors for the Treatment of Trypanosomatidic Infections 420
Accelerating Drug Discovery Efforts for Trypanosomatidic Infections Using an Integrated Transnational Academic Drug Discovery Platform 414
Internalization and stability of a thymidylate synthase peptide inhibitor in ovarian cancer cells 405
Antibacterial agent discovery using thymidylate synthase biolibrary screening 405
Conformational Propensity and Biological Studies of Proline Mutated LR Peptides Inhibiting Human Thymidylate Synthase and Ovarian Cancer Cell Growth 393
Biochemistry: Anchors away 387
Inside the biochemical pathways of thymidylate synthase perturbed by anticancer drugs: Novel strategies to overcome cancer chemoresistance 380
2′-Deoxyuridine 5′-Monophosphate Substrate Displacement in Thymidylate Synthase through 6-Hydroxy-2H-naphtho[1,8-bc]furan-2-one Derivatives 377
X-ray crystal structures of Enterococcus faecalis thymidylate synthase with folate binding site inhibitors 376
Proteomic and bioinformatic studies for the characterization of response to pemetrexed in platinum drug resistant ovarian cancer 370
Profiling of Flavonol Derivatives for the Development of Antitrypanosomatidic Drugs 367
The Hippo Pathway and YAP/TAZ-TEAD Protein-Protein Interaction as Targets for Regenerative Medicine and Cancer Treatment 366
Allosteric Inhibition of human Thymidylate Synthase. 363
Thymidylate synthase structure, function and implication in drug discovery 361
Structure-Based Selectivity Optimization of Piperidine–Pteridine Derivatives as Potent Leishmania Pteridine Reductase Inhibitors 359
Improving specificity vs bacterial thymidylate synthases through N-dansyl modulation of didansyltyrosine 357
Crystal Structure of human thymidylate synthase bound to a peptide inhibitor 353
Dimer-monomer equilibrium of human thymidylate synthase monitored by fluorescence resonance energy transfer 351
NUOVE MOLECOLE, PER USO COME AGENTI ANTITUMORALI 349
Crystal Structure of histidine-tagged human thymidylate synthase 348
Maxwell A: F1000Prime Recommendation of Evaluation [Neres J et al., ACS Chem Biol 2014]. In F1000Prime, 09 Jan 2015; DOI: 10.3410/f.725248139.793502885. F1000Prime.com/725248139#eval793502885 348
A proteomic approach to investigate the mechanism of action of anticancer peptides 347
Current and Future Chemotherapy for Chagas Disease 345
Development of flavonoids derivatives as leads against Leishmaniasis and Trypanosomiasis-invited lecture 344
Discovery of potent pteridine reductase inhibitors to guide antiparasite drug development 343
Design and characterization of a mutation outside the active site of human thymidylate synthase that affects ligand binding 340
Modulation of the expression of folate cycle enzymes and polyamine metabolism by berberine in cisplatin-sensitive and -resistant human ovarian cancer cells 335
ANTICANCER DRUGS 333
Exploiting the 2-Amino-1,3,4-thiadiazole Scaffold To InhibitTrypanosoma bruceiPteridine Reductase in Support of Early-Stage Drug Discovery 333
Methoxylated 2'-hydroxychalcones as antiparasitic hit compounds 328
“A step further in the discovery of phthalein derivatives as Thymidylate Synthase inhibitors” 328
Hotspots in an obligate homodimeric anticancer target. structural and functional effects of interfacial mutations in human thymidylate synthase 328
QUINOXALINE DERIVATIVES AS ANTITUBERCULOSIS AGENTS 324
Homodimeric Enzymes as Drug Targets 320
Biochemical effects of riluzole on Leishmania parasites 320
Ligand-based discovery of N-(1,3-dioxo-1H,3H-benzo[de]isochromen-5-yl)-carboxamide and sulfonamide derivatives as thymidylate synthase A inhibitors 319
Alternative strategies in medicinal chemistry to face drug resistance in anticancer therapy. 316
Peptides binding to the dimer interface of thymidylate synthase for the treatment of cancer-US8916679 “B2 - Granted patent as second publication”. 315
Human Thymidylate Synthase Inhibitors Halting Ovarian Cancer Growth 314
Comparing Drug Images and Repurposing Drugs with BioGPS and FLAPdock: The Thymidylate Synthase Case 305
Protein-protein interaction inhibitors: case studies on Small Molecules and Natural Compounds. 301
Targeting the trypanosomatidic enzymes pteridine reductase and dihydrofolate reductase. 300
Intrinsic Fluorescence of the Active and the Inactive Functional Forms of Human Thymidylate Synthase 300
Tethering low affinity ligands to the dimeric interface of human thymidylate synthase. 299
Identification of the binding modes of N-phenylphthalimides inhibiting bacterial thymidylate synthase through X-ray crystallography screening 299
SAR Studies and Biological Characterization of a Chromen-4-one Derivative as an Anti-Trypanosoma brucei Agent 298
Destabilizers of the thymidylate synthase homodimer accelerate its proteasomal degradation and inhibit cancer growth 295
Update on antifolate drugs targets 292
Zing meeting on Medicinal Chemistry 2012-Lanzarote-invitated lecture 291
Inhibitor of Ovarian Cancer Cells growth by Virtual Screening: A New Thiazole Derivative Targeting Human Thymidylate Synthase 290
Target-based approaches for the discovery of new antimycobacterial drugs 281
Dal Ligand based design di inibitori della Timidilato Sintasi all'Analisi Comparativa dei Complessi Enzima-Inibitore 275
Aza-boronic acids as non-beta-lactam inhibitors of AmpC-beta-lactamase 272
FRET-based assay for sensing a cancer key protein functional state and inhibition by oligopeptides: Sitespecific Protein Chemical Modifications 264
Peptides binding to the dimer interface of thymidylate synthase for the treatment of cancer 261
COMPOSTI AD ATTIVITÀ ANTIPARASSITARIA 255
The structure of Cryptococcus neoformans thymidylate synthase suggests strategies for using target dynamics for species-specific inhibition 254
Unusual Targeting of the human Thymidylate synthase interface: a tethering approach with mass-spectrometric detection. 253
Fragment Based Discovery of Thymidylate Synthase Dimeric Interface Inhibitors Through Mass Spectrometry. Invited lecture to the Fragment Based Lead Discovery track. 251
Compounds having antiparasitic activity 251
Synthesis of N-(5,7-diamino-3-phenyl-quinoxalin-2-yl)-3,4,5-substituted anilines and N-[4[(5,7-diamino-3-phenylquinoxalin-2-yl)amino]benzoyl]-l-glutamic acid diethyl ester: evaluation of in vitro anti-cancer and anti-folate activities 239
Scaffolds and Biological Targets Avenue to Fight Against Drug Resistance in Leishmaniasis 232
Interfering with Human Thymidylate Synthase Dimerization against ovarian human carcinoma 229
Anti-Parasitic drugsDiscovery of potent pteridine reductase inhibitors to guide antiparasite drug development. 227
Congress on - Medicinal Chemistry in parasitology: new avenues in drug discovery-organised in Modena in 2007. 227
Interfering with Human Thymidylate Synthase Dimerization anti peptide design in the search of anticancer agents against ovarian human carcinoma 225
Novel 3-benzoyl-2-piperazinylquinoxaline derivatives as potential antitumor agents 216
Hits and Lead Discovery in the Identification of New Drugs against the Trypanosomatidic Infections 215
The structure of Enterococcus faecalis thymidylate synthase provides clues about folate bacterial metabolism 210
Inhibitor Specificity via Protein Dynamics. Insights from the Design of Antibacterial Agents Targeted Against Thymidylate Synthase 209
Ovarian Cancer Drug Resistance 206
The discovery of aryl-2-nitroethyl triamino pyrimidines as anti-Trypanosoma brucei agents 203
Rapid-Throughput Technologies Applied to the Discovery of New Hits against Thymidylate synthase Enzymes 198
Intersite Communication in Dimeric Enzymes Highlighted by Structural and Thermodynamic Analysis of Didansyltyrosine Binding to Thymidylate Synthases 181
From ligand-based design to Hit validation of new thymidylate synthase inhibitors 179
International Congress.Drug resistance in ovarian cancer:bomarkers andtreatments. 174
Medicinal chemistry in parasitology 173
Sequence-based identification of specific drug target regions in the thymidylate synthase enzyme family 161
Laboratory of reference for trypanosomatidic infections -In-Vitro-and-In-Vivo-Screenings-of-New-Antiparasitic-Compounds-State-of-the-art-and-New-Developments-COST B22 139
European COST B22 Lab for antiparasitic drug screening (http://www.icp.ucl.ac.be/cost/costB22/ screening_survey.pdf )-2008-2012. 134
Totale 28.975
Salva come PNG Salva come JPEG
Categoria #
all - tutte 98.607
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 98.607
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.805 0 0 184 103 81 213 98 140 227 134 404 221
2022/20232.254 243 282 162 226 220 309 52 212 236 50 134 128
2023/20241.800 54 92 114 128 608 184 95 153 69 38 109 156
2024/20254.190 191 60 134 274 817 538 325 230 401 162 474 584
2025/20267.959 456 309 563 906 1.222 557 1.036 388 834 794 455 439
2026/2027772 208 551 13 0 0 0 0 0 0 0 0 0
Totale 28.975